These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
74 related items for PubMed ID: 7972208
1. High affinity nerve growth factor receptor expression (gp140trkA), N-myc amplification, histopathology, and survival in neuroblastoma. Miyake M, Suzuki T, Shimada H, Stram D, Seeger RC. Prog Clin Biol Res; 1994; 385():163-8. PubMed ID: 7972208 [No Abstract] [Full Text] [Related]
2. Clinical significance of expression of neurotrophic factors and their receptors in neuroblastoma. Nakagawara A, Arima-Nakagawara M, Azar CG, Scavarda NJ, Brodeur GM. Prog Clin Biol Res; 1994; 385():155-61. PubMed ID: 7972207 [No Abstract] [Full Text] [Related]
9. trk A gene expression in neuroblastoma. The clinical significance of an immunohistochemical study. Tanaka T, Hiyama E, Sugimoto T, Sawada T, Tanabe M, Ida N. Cancer; 1995 Sep 15; 76(6):1086-95. PubMed ID: 8625212 [Abstract] [Full Text] [Related]
10. Insulin-like growth factor-II expression is down-regulated in TrkA-transfected SK-N-AS neuroblastoma cells. Kim CJ, Chi JG, Thiele CJ. Lab Invest; 1999 Aug 15; 79(8):1007-13. PubMed ID: 10462038 [Abstract] [Full Text] [Related]
11. Coexpression of messenger RNA for TRK protooncogene and low affinity nerve growth factor receptor in neuroblastoma with favorable prognosis. Kogner P, Barbany G, Dominici C, Castello MA, Raschellá G, Persson H. Cancer Res; 1993 May 01; 53(9):2044-50. PubMed ID: 8481906 [Abstract] [Full Text] [Related]
12. Lack of high-affinity nerve growth factor receptors in aggressive neuroblastomas. Suzuki T, Bogenmann E, Shimada H, Stram D, Seeger RC. J Natl Cancer Inst; 1993 Mar 03; 85(5):377-84. PubMed ID: 8433391 [Abstract] [Full Text] [Related]
13. Expression of nerve growth factor receptor mRNAs and clinical response to retinoic acid in neuroblastoma. Kogner P, Barbany G, Persson H, Söderhäll S, Ahström L, Björk O. Prog Clin Biol Res; 1994 Mar 03; 385():147-53. PubMed ID: 7972206 [Abstract] [Full Text] [Related]
14. Neuroblastoma: inverse relationship between expression of N-myc and NGF-r. Christiansen H, Christiansen NM, Wagner F, Altmannsberger M, Lampert F. Oncogene; 1990 Mar 03; 5(3):437-40. PubMed ID: 2156211 [Abstract] [Full Text] [Related]
15. Coexpression of mRNA for the full-length neurotrophin receptor trk-C and trk-A in favourable neuroblastoma. Svensson T, Rydén M, Schilling FH, Dominici C, Sehgal R, Ibáñez CF, Kogner P. Eur J Cancer; 1997 Oct 03; 33(12):2058-63. PubMed ID: 9580079 [Abstract] [Full Text] [Related]
17. Expression of TrkC in favorable human neuroblastomas. Yamashiro DJ, Nakagawara A, Ikegaki N, Liu XG, Brodeur GM. Oncogene; 1996 Jan 04; 12(1):37-41. PubMed ID: 8552397 [Abstract] [Full Text] [Related]
18. Stage 4S neuroblastoma: what makes it special? Matthay KK. J Clin Oncol; 1998 Jun 04; 16(6):2003-6. PubMed ID: 9626196 [No Abstract] [Full Text] [Related]
19. Decreased TrkA gene expression in cholinergic neurons of the striatum and basal forebrain of patients with Alzheimer's disease. Boissiere F, Faucheux B, Ruberg M, Agid Y, Hirsch EC. Exp Neurol; 1997 May 04; 145(1):245-52. PubMed ID: 9184126 [Abstract] [Full Text] [Related]
20. Expression of the apoptosis-suppressing protein bcl-2, in neuroblastoma is associated with unfavorable histology and N-myc amplification. Castle VP, Heidelberger KP, Bromberg J, Ou X, Dole M, Nuñez G. Am J Pathol; 1993 Dec 04; 143(6):1543-50. PubMed ID: 8256847 [Abstract] [Full Text] [Related] Page: [Next] [New Search]